Latest Breaking News On - Transcription modulator - Page 1 : comparemela.com

Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress

HOUSTON, May 16, 2024 /PRNewswire/ Moleculin Biotech, Inc., , a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today.

United statesJenene thomasWolframcm dempkeMoleculin biotech incPrnewswire moleculin biotech incEuropean chief medical officerMoleculin biotechTranscription modulator

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJenene thomasPriya kumthekarWalter klempNorthwestern university investigative new drugMoleculin biotech incNorthwestern universitySecurities exchangeExchange commissionAmy heimberger at northwestern universityDrug administrationNational institutes of healthInvestigator initiated phaseMoleculin biotechInvestigative new drugNational institutes

Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update

Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesMichael andreeffPreliposomal annamycin lyophilizateJenene thomasCytarabine annaraWalter klempMartin tallmanExchange commissionTrademark officeDevelopment programMoleculin biotech incPrnewswire moleculin biotech incAmerican association for cancer researchEuropean medicines agencySecurities exchangeChief executive officer

Moleculin Announces U S Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin

Moleculin Announces U S Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of texasJenene thomasLiposomal annamycinWalter klempPrnewswire moleculin biotech incSecurities exchangeUniversity of texas system board regentsExchange commissionMoleculin biotech incTrademark officeIssue notificationUnited states patentReconstituting liposomalTexas system boardInstitutional conflict

Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast

Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesJenene thomasMoleculin biotech incPrnewswire moleculin biotech incMoleculin biotech conferenceMoleculin biotechTranscription modulator